🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is examining how well a dry powder inhaler (DPI) of albuterol me...
Status
Completed
Location
Teva Clinical Study Site
Start Date
2010-02
Trial ID
NCT01058863
Treatments Being Tested
The primary objective of this study is to compare the pharmacokinetic (PK) ...
Status
Completed
Location
Teva Investigational Site 10538
Start Date
2013-04
Trial ID
NCT01844401
Treatments Being Tested
This is a one-year study to look at the safety of a dry powder inhaler with...
Status
Terminated
Location
Teva Clinical Study Site
Start Date
2010-10
Trial ID
NCT01218009
Treatments Being Tested
The study will measure the change in lung function in subjects with asthma ...
Status
Completed
Location
Teva Investigational Site 10077
Start Date
2012-12
Trial ID
NCT01424813
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of a single...
Status
Completed
Location
Teva Investigational Site 10557
Start Date
2013-03
Trial ID
NCT01791972
Treatments Being Tested
The purpose of this study is to evaluate the safety of Albuterol Spiromax® ...
Status
Completed
Location
Teva Investigational Site 10169
Start Date
2012-10
Trial ID
NCT01698320
Treatments Being Tested
Study to investigate the effects of symptom-driven maintenance and reliever...
Status
Unknown
Location
University Medical Center Groningen
Start Date
2015-05-01
Trial ID
NCT02477397
Treatments Being Tested
The primary objective of this study is to evaluate the dose response, effic...
Status
Completed
Location
Teva Investigational Site 10504
Start Date
2012-04
Trial ID
NCT01576718
Treatments Being Tested
This is a prospective, open-label, multicenter Phase 3 study evaluating the...
Status
Completed
Location
Teva Investigational Site 10620
Start Date
2013-05
Trial ID
NCT01857323
Treatments Being Tested
The study is to evaluate the chronic-dose efficacy and the safety of Albute...
Status
Completed
Location
Teva Investigational Site 12496
Start Date
2014-05
Trial ID
NCT02126839
Treatments Being Tested